Publications by authors named "Donald Berry"

Claim this Profile
S
Statistical innovations in clinical trial design with a focus on drug combinations, factorials, and other multiple therapy issues.
Donald A Berry

J Prev Alzheimers Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research.
Donald A Berry

J Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annual Versus Biennial Mammographic Screening.
Donald A Berry

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer.
Hope S Rugo, Mike Campbell, Christina Yau, A Jo Chien, Anne M Wallace, Donald A Berry

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation.
Jeffrey Cummings, Michael Gold, Mark Mintun, Michael Irizarry, Andrew von Eschenbach, Donald Berry

J Prev Alzheimers Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.
Michael J Campbell, Denise M Wolf, Christina Yau, Lamorna Brown-Swigart, Julie Wulfkuhle, Donald A Berry

Cell Rep Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Amy Trentham-Dietz, Christina Hunter Chapman, Jinani Jayasekera, Kathryn P Lowry, Brandy M Heckman-Stoddard, Donald Berry

JAMA· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis.
Nathalie A Waser, Melanie Quintana, Bernd Schweikert, Jamie E Chaft, Lindsay Berry, Donald A Berry

JNCI Cancer Spectr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Scott Berry, Donald A Berry

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Breast Cancer Mortality in the US-1975 to 2019.
Jennifer L Caswell-Jin, Liyang P Sun, Diego Munoz, Ying Lu, Yisheng Li, Donald A Berry

JAMA· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial.
Donald A Berry, Shobha Dhadda, Michio Kanekiyo, David Li, Chad J Swanson, Scott M Berry

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Donald A Berry

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis.
Nicholas J Short, Chenqi Fu, Donald A Berry, Roland B Walter, Sylvie D Freeman

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Arash Jamshidi, Minetta C Liu, Eric A Klein, Oliver Venn, Earl Hubbell, Donald A Berry

Cancer Cell· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, Scott Berry, Donald A Berry

NPJ Breast Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
Shobha Dhadda, Michio Kanekiyo, David Li, Chad J Swanson, Michael Irizarry, Scott Berry, Donald A Berry

Alzheimers Res Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Temperature Management Using Esophageal Cooling.
Cedar Morrow Anderson, Christopher Joseph, Rick Fisher, Donald Berry, J Brad Diestelhorst

Ther Hypothermia Temp Manag· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials.
Benjamin R Saville, Donald A Berry, Nicholas S Berry, Kert Viele, Scott M Berry

Clin Trials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.
Henry Hiep Vo, Siqing Fu, David S Hong, Daniel D Karp, Sarina Piha-Paul, Donald A Berry

NPJ Precis Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
Denise M Wolf, Christina Yau, Julia Wulfkuhle, Lamorna Brown-Swigart, Rosa I Gallagher, Donald A Berry

Cancer Cell· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative Addition of Silicon-Chloride Bonds to a Zerovalent Ruthenium Center and Direct Generation of an Ethylene Insertion Complex.
Hyojong Yoo, Donald H Berry

Inorg Chem· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Bayesian vs Frequentist Adaptive Trial Design in the Stroke Hyperglycemia Insulin Network Effort Trial.
Kristine Broglio, William J Meurer, Valerie Durkalski, Qi Pauls, Jason Connor, Donald Berry

JAMA Netw Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Chad J Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Donald A Berry, Scott Berry

Alzheimers Res Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis